[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):112-128. doi: 10.3760/cma.j.issn.1007-3418.2020.02.004.

DOI:10.3760/cma.j.issn.1007-3418.2020.02.004

PMID:32164061

Abstract

摘要

相似文献

[1]

[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].

Zhonghua Gan Zang Bing Za Zhi. 2020-2-20

[2]

Advances in Hepatocellular Carcinoma.

Clin Liver Dis. 2020-11

[3]

Consensus and controversy in the management of hepatocellular carcinoma.

J Am Coll Surg. 2007-7

[4]

Hepatocellular carcinoma (primary cancer of the liver).

Gastroenterol Clin Biol. 2006-9

[5]

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Hepatology. 2018-8

[6]

Hepatocellular carcinoma in children.

Clin Liver Dis. 2015-2-28

[7]

Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?

Liver Transpl. 2011-10

[8]

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.

Oncology. 2007

[9]

[Progress in the diagnosis and treatment of small hepatocellular carcinoma].

Zhonghua Nei Ke Za Zhi. 1994-11

[10]

Diagnosis and management of carcinoma of the liver.

J Am Med Womens Assoc (1972). 1984

引用本文的文献

[1]

Transarterial chemoembolization for advanced hepatocellular carcinoma after failure of first-line systemic treatment: a single-center case series.

Discov Oncol. 2025-8-8

[2]

Hepatic artery infusion chemotherapy combined with lenvatinib and PD-1 inhibitors in the treatment of intermediate and advanced unresectable hepatocellular carcinoma.

Oncol Lett. 2025-7-9

[3]

Discovery of novel diagnostic biomarkers of hepatocellular carcinoma associated with immune infiltration.

Ann Med. 2025-12

[4]

Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study.

Acta Oncol. 2025-5-5

[5]

Diagnostic and prognostic performance of serum GPC3 and PIVKA-II in AFP-negative hepatocellular carcinoma and establishment of nomogram prediction models.

BMC Cancer. 2025-4-17

[6]

Spleen volume after stage-I associated liver partition and portal vein ligation for staged hepatectomy predicts future liver remnant.

Langenbecks Arch Surg. 2025-4-15

[7]

Analysis of high-risk factors for hepatocellular carcinoma after sustained virological suppression of chronic hepatitis B.

BMC Cancer. 2025-4-8

[8]

Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features.

J Gastrointest Oncol. 2025-2-28

[9]

Plasma microRNA-15a/16-1-based machine learning for early detection of hepatitis B virus-related hepatocellular carcinoma.

Liver Res. 2024-5-24

[10]

A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers.

BMC Cancer. 2025-1-21

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)].

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献